
Erypro Safe 10000IU Injection
Marketer
Eris Oaknet Healthcare Pvt Ltd
Salt Composition
Recombinant Human Erythropoietin Alfa (10000IU)
Overview Erypro Safe 10000IU Injection
Epoetin alfa 10,000 IU injection stimulates red blood cell production in the bone marrow. It's indicated for anemia related to chronic kidney disease, cancer chemotherapy, or HIV medication. Administered subcutaneously or intravenously (as determined by your physician), injections are typically given by a healthcare professional. Dosage is weight-based and depends on the anemia's cause. Concurrent iron supplementation may enhance efficacy. Store refrigerated but allow to reach room temperature before use. Common side effects include nausea, vomiting, fever, and hypertension; flu-like symptoms (headache, fatigue, dizziness, myalgia) are also possible, often subsiding as treatment progresses. Persistent symptoms should be discussed with your doctor. Report serious side effects immediately, including seizures. Serious thromboembolic events require urgent medical attention. Inform your physician of uncontrolled hypertension, heart disease, or gout prior to commencing treatment, and disclose all other medications. Regular blood pressure monitoring is essential. Further testing may be necessary to monitor for adverse effects. The effects of this medication on pregnancy are unknown; inform your doctor if pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Erypro Safe 10000IU Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Erypro Safe 10000IU Injection
Managing anemia resulting from cancer treatment or chronic kidney failure.
Major Benefits of Erypro Safe 10000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Erypro Safe 10000IU Injection:
- High blood pressure
- Nausea
- Vomiting
- Fever
- Rash
- Joint pain
- Headache
- Insomnia (difficulty in sleeping)
- Chills
- Cough
- Bone pain
- Muscle spasm
- Dizziness
- Vascular occlusion
- Injection site irritation
- Stomatitis (Inflammation of the mouth)
- Weight loss
- Decreased white blood cell count (lymphocytes)
- Increased glucose level in blood
- Blood clot in the blood vessels
How to use Erypro Safe 10000IU Injection:
Administering this medication will be handled by your physician or their nursing staff; self-medication is strictly prohibited.
How Erypro Safe 10000IU Injection works:
Erypro Safe 10000IU Injection, an erythropoiesis stimulator, boosts red blood cell production by prompting increased activity within the bone marrow, the blood cell-generating tissue found inside bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erypro Safe 10000IU Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Erypro Safe 10000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding mothers should likely avoid Erypro Safe 10000IU Injection. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administration of Erypro Safe 10000IU Injection may induce adverse reactions that could impair driving capabilities.
KidneySAFE IF PRESCRIBED
Erypro Safe 10000IU Injection can be administered to patients with renal impairment without dosage modification. However, routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver conditions should use Erypro Safe 10000IU Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Erypro Safe 10000IU Injection :
Omit a scheduled Erypro Safe 10000IU Injection? Seek medical advice.
Facts to Know About Erypro Safe 10000IU Injection
Label | Value |
---|---|
Chemical Category | Amino Acid and Peptide Analogs |
Developing Habits | No. |
Treatment Category | KINSHIP |